Cultivated Enterococcus faecium B6 from children with obesity promotes nonalcoholic fatty liver disease by the bioactive metabolite tyramine
Authors:
Open Access
- 13 May 2024
- journal article
- research article
- Published by Taylor & Francis in Gut Microbes
- Vol. 16 (1) , 2351620
Abstract
Gut microbiota plays an essential role in nonalcoholic fatty liver disease (NAFLD). However, the contribution of individual bacterial strains and their metabolites to childhood NAFLD pathogenesis remains poorly understood. Herein, the critical bacteria in children with obesity accompanied by NAFLD were identified by microbiome analysis. Bacteria abundant in the NAFLD group were systematically assessed for their lipogenic effects. The underlying mechanisms and microbial-derived metabolites in NAFLD pathogenesis were investigated using multi-omics and LC-MS/MS analysis. The roles of the crucial metabolite in NAFLD were validated in vitro and in vivo as well as in an additional cohort. The results showed that Enterococcus spp. was enriched in children with obesity and NAFLD. The patient-derived Enterococcus faecium B6 (E. faecium B6) significantly contributed to NAFLD symptoms in mice. E. faecium B6 produced a crucial bioactive metabolite, tyramine, which probably activated PPAR-γ, leading to lipid accumulation, inflammation, and fibrosis in the liver. Moreover, these findings were successfully validated in an additional cohort. This pioneering study elucidated the important functions of cultivated E. faecium B6 and its bioactive metabolite (tyramine) in exacerbating NAFLD. These findings advance the comprehensive understanding of NAFLD pathogenesis and provide new insights for the development of microbe/metabolite-based therapeutic strategies.Keywords
Funding Information
- The National Natural Science Foundation of China (82304171)
- the Hunan Province Natural Science Foundation (2022JJ40668)
- the Fundamental Research Funds for the Central Universities of Central South University (2022ZZTS0846)
This publication has 83 references indexed in Scilit:
- Up-Regulation of PPAR-γ mRNA Expression in the Liver of Obese Patients: an Additional Reinforcing Lipogenic Mechanism to SREBP-1c InductionThe Journal of Clinical Endocrinology & Metabolism, 2011
- PER2 Controls Lipid Metabolism by Direct Regulation of PPARγCell Metabolism, 2010
- Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural AfricaProceedings of the National Academy of Sciences, 2010
- Hepatic Fatty Acid Transporter Cd36 Is a Common Target of LXR, PXR, and PPARγ in Promoting SteatosisGastroenterology, 2008
- A multifactorial design for studying factors influencing growth and tyramine production of the lactic acid bacteria Lactobacillus brevis CECT 4669 and Enterococcus faecium BIFI-58Research in Microbiology, 2006
- Progress in Monoamine Oxidase (MAO) Research in Relation to Genetic EngineeringNeuroToxicology, 2004
- Identification of theEnterococcus faecalisTyrosine Decarboxylase Operon Involved in Tyramine ProductionApplied and Environmental Microbiology, 2002
- Steatohepatitis: A tale of two “hits”?Gastroenterology, 1998
- Tyramine kinetics and metabolism in cirrhosis.Journal of Clinical Investigation, 1979
- Genetic mapping of tyramine oxidase and arylsulfatase genes and their regulation in intergeneric hybrids of enteric bacteriaJournal of Bacteriology, 1978